Olanzapine-Induced Diabetic Ketoacidosis and Neuroleptic Malignant Syndrome with Rhabdomyolysis: A Case Report

Atypical antipsychotics have replaced conventional antipsychotics in the treatment of schizophrenia because they have less of a propensity to cause undesirable neurologic adverse events including extrapyramidal symptoms, tardive dyskinesia, and neuroleptic malignant syndrome (NMS). However, atypical...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Young Kyoung Sa, Hyeon Yang, Hee Kyoung Jung, Jang Won Son, Seong Su Lee, Seong Rae Kim, Bong Yeon Cha, Ho Young Son, Chi-Un Pae, Soon Jib Yoo
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Korean Endocrine Society 2013-03-01
Saila:	Endocrinology and Metabolism
Gaiak:	Diabetic ketoacidosis Neuroleptic malignant syndrome Olanzapine
Sarrera elektronikoa:	http://e-enm.org/Synapse/Data/PDFData/2008ENM/enm-28-70.pdf
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!